Aim and scope

Journal of Pulmonary Research and Therapeutics is an international journal of high repute covering topics of interest to all those researching and lung pharmacology from molecular to clinical aspects. On the basis of its originality, importance, interdisciplinary interest, accessibility, timeliness, elegance, and novelty.

Journal of Pulmonary Research and Therapeutics (JPRT) aim is to provide a platform to serve researchers through prompt publication of significant advances in the field of lung pharmacology and to provide a forum for the reporting and discussion of latest updates, progress, and application of scientific discoveries in immunology and respiratory research. JPRT will keep up to date with the latest advances and innovations in this field by providing free access to the research information.

JPRT Publishes articles exploring concepts, strategies, approaches, and issues of relevance to lung pharmacology which make a significant and original contribution to theory and practice. These articles present innovative ideas, best practices, and leading-edge thinking about all aspects of publishing, authorship, and readership. Journal ensures that the results of science experiments are rapidly disseminated to the scientific community and public immediately after publication, thus providing higher citation rates for the author.

The Journal of Pulmonary Research and Therapeutics (JPRT) is committed to publishing scholarly empirical and theoretical research articles, that have a high impact on lung Pharmacology. The journal encourages new ideas or new perspectives on existing research.

It welcomes and acknowledges high-quality theoretical and empirical original research articles, case reports, review articles, short communications, literature reviews, editorials, conceptual frameworks, short reviews from academicians, scientists, professionals, practitioners, and scholars from all over the world.

JPRT have a broad scope and welcome submissions from across a range of disciplines, and all aspect of lung pharmacology from molecular to clinical aspects and practice that will make an advanced improvement in this field. Articles written from a theoretical or applied perspective are welcome.

The journal covers subject areas but not limited to:
  • Acute Bronchitis
  • Acute Respiratory Distress Syndrome
  • Bronchopulmonary Dysplasia
  • Coccidioidomycosis
  • Emphysema
  • Hantavirus Pulmonary Syndrome
  • Human Metapneumovirus
  • Idiopathic Pulmonary Fibrosis
  • Interventional Pulmonology
  • Lymphangiomatosis
  • Nontuberculosis Mycobacterium
  • Primary Pulmonary Hypertension
  • Pulmonary Arterial Hypertension
  • Pulmonary Distress
  • Pulmonary Edema
  • Pulmonary Fibrosis
  • Pulmonary Parenchymal Disease
  • Pulmonary Vascular Disease
  • Wegener's Granulomitis

Contact Us

Scientific Eminence Group

Scientific Eminence Group journals follows and maintain highest standards of quality, with strong Editorial Boards composed of renowned professors and scientists from around the world. It is an International repository for accepted and published research work of various countries researchers.

1649, Whispering wind, Dr Tracy, CA 95377

jprt@scientificeminencegroup.com

+1(969)274-0389